Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
22.41
-0.29 (-1.28%)
Apr 2, 2025, 2:45 PM CST
SHE:002262 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 23,067 | 24,744 | 27,326 | 24,736 | 15,769 | 16,092 | Upgrade
|
Market Cap Growth | -9.45% | -9.45% | 10.47% | 56.87% | -2.01% | 35.74% | Upgrade
|
Enterprise Value | 19,320 | 20,984 | 23,972 | 21,956 | 13,322 | 13,929 | Upgrade
|
Last Close Price | 22.70 | 24.35 | 26.77 | 24.06 | 15.09 | 15.31 | Upgrade
|
PE Ratio | 20.09 | 21.64 | 26.35 | 27.46 | 19.77 | 22.08 | Upgrade
|
Forward PE | 17.53 | 18.59 | 22.41 | 24.31 | 17.58 | 18.30 | Upgrade
|
PS Ratio | 4.03 | 4.34 | 5.42 | 5.76 | 4.01 | 4.79 | Upgrade
|
PB Ratio | 3.16 | 3.40 | 4.26 | 4.43 | 3.22 | 3.92 | Upgrade
|
P/TBV Ratio | 3.50 | 3.50 | 4.38 | 4.49 | 3.27 | 4.00 | Upgrade
|
P/FCF Ratio | 49.49 | 53.09 | 43.08 | 46.39 | 31.86 | 16.43 | Upgrade
|
P/OCF Ratio | 27.01 | 27.01 | 27.10 | 28.73 | 22.49 | 12.89 | Upgrade
|
PEG Ratio | 1.03 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | Upgrade
|
EV/Sales Ratio | 3.39 | 3.68 | 4.76 | 5.11 | 3.39 | 4.14 | Upgrade
|
EV/EBITDA Ratio | 13.85 | 15.38 | 19.90 | 21.43 | 13.88 | 15.86 | Upgrade
|
EV/EBIT Ratio | 15.92 | 17.30 | 22.41 | 24.35 | 15.72 | 17.82 | Upgrade
|
EV/FCF Ratio | 41.45 | 45.02 | 37.79 | 41.17 | 26.91 | 14.22 | Upgrade
|
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 0.05 | 0.05 | 0.09 | 0.09 | 0.11 | 0.04 | Upgrade
|
Debt / FCF Ratio | 0.15 | 0.15 | 0.18 | 0.17 | 0.22 | 0.04 | Upgrade
|
Asset Turnover | 0.72 | 0.72 | 0.73 | 0.71 | 0.75 | 0.75 | Upgrade
|
Inventory Turnover | 2.40 | 2.40 | 2.09 | 1.57 | 1.80 | 2.16 | Upgrade
|
Quick Ratio | 5.00 | 5.00 | 5.64 | 4.88 | 5.01 | 4.99 | Upgrade
|
Current Ratio | 5.68 | 5.68 | 6.46 | 5.86 | 5.93 | 5.77 | Upgrade
|
Return on Equity (ROE) | 16.67% | 16.67% | 17.25% | 16.78% | 17.72% | 18.86% | Upgrade
|
Return on Assets (ROA) | 9.62% | 9.62% | 9.68% | 9.25% | 10.14% | 10.91% | Upgrade
|
Return on Capital (ROIC) | 10.94% | 10.94% | 10.96% | 10.54% | 11.56% | 12.55% | Upgrade
|
Return on Capital Employed (ROCE) | 16.50% | 16.50% | 16.40% | 15.90% | 16.90% | 18.70% | Upgrade
|
Earnings Yield | 4.96% | 4.62% | 3.79% | 3.64% | 5.06% | 4.53% | Upgrade
|
FCF Yield | 2.02% | 1.88% | 2.32% | 2.16% | 3.14% | 6.09% | Upgrade
|
Dividend Yield | 1.59% | 1.48% | 1.20% | 0.83% | 1.32% | 0.65% | Upgrade
|
Payout Ratio | 28.31% | 28.31% | 19.54% | 22.37% | 12.63% | 13.98% | Upgrade
|
Buyback Yield / Dilution | -0.53% | -0.53% | 0.53% | -0.22% | 0.24% | -0.72% | Upgrade
|
Total Shareholder Return | 1.06% | 0.95% | 1.72% | 0.61% | 1.56% | -0.07% | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.